These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


192 related items for PubMed ID: 3093995

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis and some reactions of 1-methyl-1H-2-cyanomethyl-imidazo[4,5-b]pyridine. Tuberculostatic activity of obtained compounds.
    Bukowski L, Janowiec M.
    Pharmazie; 1990 Dec; 45(12):904-7. PubMed ID: 2129248
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Imidazo[4,5-b]pyridine derivatives of potential tuberculostatic activity, II: Synthesis and bioactivity of designed and some other 2-cyanomethylimidazo[4,5-b]pyridine derivatives.
    Bukowski L, Kaliszan R.
    Arch Pharm (Weinheim); 1991 Sep; 324(9):537-42. PubMed ID: 1793358
    [Abstract] [Full Text] [Related]

  • 10. Synthesis of imidazo [4,5-b] pyridine-7-carboxylic acid and some of its derivatives with expected antituberculous activity.
    Bukowski L.
    Pol J Pharmacol Pharm; 1980 Sep; 32(5):767-72. PubMed ID: 6791143
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Synthesis and tuberculostatic activity of various derivatives of 2-mercaptoimidazo [4,5-c] pyridine].
    Czarnocka-Janowicz A, Sawlewicz J, Jakubowski J, Janowiec M.
    Acta Pol Pharm; 1979 Sep; 36(5):529-37. PubMed ID: 121515
    [No Abstract] [Full Text] [Related]

  • 13. Some reactions of 2-cyanomethyl-3-methyl-3H-imidazo[4,5-b]pyridine with isothiocyanates. Antituberculotic activity of the obtained compounds.
    Bukowski L.
    Pharmazie; 2001 Jan; 56(1):23-7. PubMed ID: 11210662
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis, transformations and tuberculostatic activity of 1-(N-aroylthiocarbamoyl)imidiazolidine-2-thiones.
    Saczewski F.
    Acta Pol Pharm; 1993 Jan; 50(4-5):341-4. PubMed ID: 8036919
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and antitubercular screening of imidazole derivatives.
    Pandey J, Tiwari VK, Verma SS, Chaturvedi V, Bhatnagar S, Sinha S, Gaikwad AN, Tripathi RP.
    Eur J Med Chem; 2009 Aug; 44(8):3350-5. PubMed ID: 19272678
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives.
    Mamolo MG, Vio L, Banfi E, Predominato M, Fabris C, Asaro F.
    Farmaco; 1993 Apr; 48(4):529-38. PubMed ID: 8357468
    [Abstract] [Full Text] [Related]

  • 19. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors.
    Odell LR, Nilsson MT, Gising J, Lagerlund O, Muthas D, Nordqvist A, Karlén A, Larhed M.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4790-3. PubMed ID: 19560924
    [Abstract] [Full Text] [Related]

  • 20. In vitro tuberculostatic activities of some 2-benzylbenzimidazole and 2-phenoxymethylbenzimidazole derivatives.
    Gümüs F, Altuntas TG, Saygun N, Ozden T, Ozden S.
    J Pharm Belg; 1989 Aug 15; 44(6):398-402. PubMed ID: 2517303
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.